Brian J. Lynch

Insider Reports History

Location
Blue Bell, PA
Signature
/s/ Brian J. Lynch
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian J. Lynch:

Company Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. SVP and General Counsel Common Stock 17,691 $4,315,189 $243.92 23 Jan 2024 Direct
MADRIGAL PHARMACEUTICALS, INC. SVP and General Counsel Market Stock Unit 3,639 $887,625 $243.92 23 Jan 2024 Direct
MADRIGAL PHARMACEUTICALS, INC. SVP and General Counsel Common Stock 530 $129,278 $243.92 23 Jan 2024 In IRA
MADRIGAL PHARMACEUTICALS, INC. SVP and General Counsel Stock Option (Right to Buy) 5,483 23 Jan 2024 Direct

Insider Reports Filed by Brian J. Lynch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MDGL MADRIGAL PHARMACEUTICALS, INC. 23 Jan 2024 3 $0 4 SVP and General Counsel 25 Jan 2024, 15:24
MDGL MADRIGAL PHARMACEUTICALS, INC. 16 Jan 2024 1 -$231,480 4 SVP and General Counsel 18 Jan 2024, 13:52
MDGL MADRIGAL PHARMACEUTICALS, INC. 04 Dec 2023 9 -$388,114 4 SVP and General Counsel 06 Dec 2023, 16:30
MDGL MADRIGAL PHARMACEUTICALS, INC. 29 Nov 2023 9 -$894,230 4 SVP and General Counsel 01 Dec 2023, 16:30
MDGL MADRIGAL PHARMACEUTICALS, INC. 16 Jan 2023 1 $0 4 SVP and General Counsel 18 Jan 2023, 19:00
MDGL MADRIGAL PHARMACEUTICALS, INC. 03 Jan 2023 12 -$2,484,707 4 SVP and General Counsel 06 Jan 2023, 08:08
MDGL MADRIGAL PHARMACEUTICALS, INC. 23 Dec 2022 16 -$1,276,701 4 SVP and General Counsel 28 Dec 2022, 19:00
MDGL MADRIGAL PHARMACEUTICALS, INC. 10 Aug 2022 1 $0 4 SVP and General Counsel 12 Aug 2022, 16:30
MDGL MADRIGAL PHARMACEUTICALS, INC. 22 Feb 2022 1 $0 4 SVP and General Councel 24 Feb 2022, 19:18